$UMAC
Unusual Machines, Inc.

2024 Q1 Form 10-K Financial Statement

#000168316824001643 Filed on March 22, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $618.9K $0.00 $0.00
YoY Change
Cost Of Revenue $414.7K $0.00 $0.00
YoY Change
Gross Profit $204.2K $0.00 $0.00
YoY Change
Gross Profit Margin 32.99%
Selling, General & Admin $1.156M $412.4K $1.789M
YoY Change 96.42% -11.1% 55.49%
% of Gross Profit 566.17%
Research & Development $16.80K $0.00
YoY Change -100.0%
% of Gross Profit 8.23%
Depreciation & Amortization $171.00 $4.200K $5.600K
YoY Change -57.25% 366.67% 522.22%
% of Gross Profit 0.08%
Operating Expenses $1.291M $416.6K $1.794M
YoY Change 119.14% -10.37% 44.4%
Operating Profit -$1.086M -$416.6K -$1.794M
YoY Change 84.47% -10.37% 44.4%
Interest Expense $19.65K $0.00 $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net -$19.65K $0.00
YoY Change -100.0%
Pretax Income -$1.106M -$416.6K -$1.794M
YoY Change 87.81% -10.37% 44.41%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.106M -$416.6K -$1.794M
YoY Change 87.81% -10.37% 44.41%
Net Earnings / Revenue -178.7%
Basic Earnings Per Share -$0.18
Diluted Earnings Per Share -$0.18 -$0.05 -$0.54
COMMON SHARES
Basic Shares Outstanding 9.083M shares
Diluted Shares Outstanding 6.066M shares 3.307M shares

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.209M $894.8K $894.8K
YoY Change 25.48% -71.13% -71.13%
Cash & Equivalents $3.209M $894.8K $894.8K
Short-Term Investments
Other Short-Term Assets $278.3K $120.6K $633.4K
YoY Change -2.77% -46.91% 178.78%
Inventory $1.642M $0.00
Prepaid Expenses
Receivables $1.933K $0.00
Other Receivables $19.64K $0.00
Total Short-Term Assets $6.129M $1.528M $1.528M
YoY Change 115.56% -54.06% -54.06%
LONG-TERM ASSETS
Property, Plant & Equipment $1.083K $1.254K $1.250K
YoY Change -67.18% -66.11% -66.22%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $59.43K $0.00
YoY Change
Total Long-Term Assets $18.10M $1.254K $1.260K
YoY Change 548378.85% -66.11% -65.95%
TOTAL ASSETS
Total Short-Term Assets $6.129M $1.528M $1.528M
Total Long-Term Assets $18.10M $1.254K $1.260K
Total Assets $24.23M $1.529M $1.529M
YoY Change 751.17% -54.08% -54.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $455.8K $114.5K $114.5K
YoY Change 101.66% -5.29% -5.29%
Accrued Expenses $66.03K $0.00
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $692.0K $114.5K $114.5K
YoY Change 206.18% -5.3% -5.29%
LONG-TERM LIABILITIES
Long-Term Debt $2.000M $0.00 $0.00
YoY Change
Other Long-Term Liabilities $313.9K
YoY Change
Total Long-Term Liabilities $2.314M $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $692.0K $114.5K $114.5K
Total Long-Term Liabilities $2.314M $0.00 $0.00
Total Liabilities $3.006M $114.5K $114.5K
YoY Change 1230.03% -5.29% -5.29%
SHAREHOLDERS EQUITY
Retained Earnings -$4.439M -$3.333M
YoY Change 116.63%
Common Stock $93.33K $32.17K
YoY Change -5.16%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $21.22M $1.415M $1.415M
YoY Change
Total Liabilities & Shareholders Equity $24.23M $1.529M $1.529M
YoY Change 751.17% -54.08% -54.08%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$1.106M -$416.6K -$1.794M
YoY Change 87.81% -10.37% 44.41%
Depreciation, Depletion And Amortization $171.00 $4.200K $5.600K
YoY Change -57.25% 366.67% 522.22%
Cash From Operating Activities -$1.196M -$442.3K -$2.201M
YoY Change 120.39% -12.3% 78.72%
INVESTING ACTIVITIES
Capital Expenditures -$40.00 $3.164K
YoY Change -101.9% -31.22%
Acquisitions $852.9K
YoY Change
Other Investing Activities -$852.9K
YoY Change
Cash From Investing Activities -$852.9K $40.00 -$3.164K
YoY Change -101.9% -31.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $4.362M 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -$1.196M -442.3K -$2.201M
Cash From Investing Activities -$852.9K 40.00 -$3.164K
Cash From Financing Activities $4.362M 0.000
Net Change In Cash $2.314M -442.3K -$2.205M
YoY Change -526.51% -12.67% 221.14%
FREE CASH FLOW
Cash From Operating Activities -$1.196M -$442.3K -$2.201M
Capital Expenditures -$40.00 $3.164K
Free Cash Flow -$442.3K -$2.205M
YoY Change -12.67% 78.31%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001956955
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
CY2023 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
333-270519
CY2023 dei Entity Registrant Name
EntityRegistrantName
Unusual Machines, Inc.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
PR
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
66-0927642
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
4667 1 B McLeod Rd
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite J
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Orlando
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32811
CY2023 dei City Area Code
CityAreaCode
(855)
CY2023 dei Local Phone Number
LocalPhoneNumber
921-4600
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2024Q1 dei Entity Public Float
EntityPublicFloat
8100000 usd
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9083341 shares
CY2023 dei Auditor Name
AuditorName
BF Borgers CPA PC
CY2023 dei Auditor Firm
AuditorFirmId
5041
CY2023 dei Auditor Location
AuditorLocation
Lakewood, CO
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
894773 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3099422 usd
CY2023Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
512758 usd
CY2022Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
87825 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
139375 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
3326622 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1254 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3690 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1254 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
3690 usd
CY2023Q4 us-gaap Assets
Assets
1529416 usd
CY2022Q4 us-gaap Assets
Assets
3330312 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
114497 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
120938 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
114497 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
120938 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
190 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
140 shares
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
2 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
1 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3217255 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3392250 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
32173 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
33923 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4715790 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4714041 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3333046 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1538591 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1414919 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3209374 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1529416 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3330312 usd
CY2023 us-gaap Revenues
Revenues
0 usd
CY2022 us-gaap Revenues
Revenues
0 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2023 us-gaap Gross Profit
GrossProfit
0 usd
CY2022 us-gaap Gross Profit
GrossProfit
0 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
91325 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1788855 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1150522 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5600 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
885 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
1794455 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
1242732 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-1794455 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-1242732 usd
CY2023 us-gaap Interest And Other Income
InterestAndOtherIncome
0 usd
CY2022 us-gaap Interest And Other Income
InterestAndOtherIncome
148 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
148 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1794455 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1242584 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-1794455 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1242584 usd
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.54
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3307118 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4006007 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3902058 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
549900 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1242584 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3209374 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-1794455 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1414919 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-1794455 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1242584 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5600 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
885 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-0 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-945 usd
CY2023 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
424933 usd
CY2022 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
87825 usd
CY2023 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-18744 usd
CY2022 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
24153 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-6441 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
120938 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2201485 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1231794 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3164 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4575 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3164 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4575 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
549900 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
549900 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-2204649 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-686469 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3099422 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3785891 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
894773 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3099422 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_845_eus-gaap--UseOfEstimates_zpxG9nZaXeV7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">Use of Estimates</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Accordingly, actual results could differ from those estimates, and such results could be material.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2022Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2023Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
600000 usd
CY2022Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
2800000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3690 usd
CY2023 us-gaap Depreciation
Depreciation
5600 usd
CY2022 us-gaap Depreciation
Depreciation
885 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2023 UMAC Property Plant And Equipment Useful Life1
PropertyPlantAndEquipmentUsefulLife1
two to five years
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
120631 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
139375 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6484 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
885 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1254 usd
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q3 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-2 reverse stock split
CY2023 us-gaap Convertible Preferred Stock Terms Of Conversion
ConvertiblePreferredStockTermsOfConversion
The Series B preferred stock is convertible into common stock at a ratio of 5,000 shares of common stock for each share of Series B stock held, subject to certain limitations. Series B preferred shares are not entitled to vote on any matters submitted to shareholders of the Company.
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001683168-24-001643-index-headers.html Edgar Link pending
0001683168-24-001643-index.html Edgar Link pending
0001683168-24-001643.txt Edgar Link pending
0001683168-24-001643-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending
umac-20231231.xsd Edgar Link pending
unusual_ex0407.htm Edgar Link pending
unusual_ex1901.htm Edgar Link pending
unusual_ex3101.htm Edgar Link pending
unusual_ex3102.htm Edgar Link pending
unusual_ex3201.htm Edgar Link pending
unusual_ex3202.htm Edgar Link pending
unusual_ex9701.htm Edgar Link pending
unusual_i10k-123123.htm Edgar Link pending
umac-20231231_def.xml Edgar Link unprocessable
umac-20231231_lab.xml Edgar Link unprocessable
umac-20231231_pre.xml Edgar Link unprocessable
unusual_i10k-123123_htm.xml Edgar Link completed
umac-20231231_cal.xml Edgar Link unprocessable